| Not Yet Recruiting | Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria NCT07431931 | Geisinger Clinic | N/A |
| Not Yet Recruiting | Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy NCT07096986 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Recruiting | Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. NCT06858319 | Novartis Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis NCT05517980 | Kira Pharmacenticals (US), LLC. | Phase 2 |
| Recruiting | Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis NCT06835322 | Alexandria University | Phase 2 |
| Not Yet Recruiting | Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Mu NCT06792448 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland NCT06889948 | Helsinki University Central Hospital | Phase 2 |
| Recruiting | Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Ne NCT04662723 | Fondazione Schena | Phase 4 |
| Unknown | A Study of Rituximab in Frontline Therapy for Glomerulonephritis NCT05761938 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | TESTING -ON Post-Trial ObservatioNal Cohort Study NCT05434325 | The George Institute | — |
| Completed | A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy NCT05174221 | Takeda | Phase 1 |
| Completed | Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency NCT05505955 | Chengdu Suncadia Medicine Co., Ltd. | Phase 1 |
| Completed | ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES NCT06753942 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Unknown | Bortezomib for Treating Glomerular Diseases NCT05383547 | Ruijin Hospital | N/A |
| Terminated | An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases NCT04950114 | Goldfinch Bio, Inc. | Phase 2 |
| Unknown | US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis NCT04582890 | Assiut University | — |
| Unknown | Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 NCT04846010 | All Natural Medicine Clinic, LLC | Phase 1 / Phase 2 |
| Completed | Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) NCT04733040 | HI-Bio, A Biogen Company | Phase 2 |
| Active Not Recruiting | A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A NCT04663204 | University of Leicester | Phase 2 |
| Terminated | A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, NCT04387448 | Goldfinch Bio, Inc. | Phase 2 |
| Unknown | Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis NCT04349683 | Jemincare | Phase 4 |
| Completed | Empagliflozin in Patients With Glomerulonephritis NCT05283057 | Kasr El Aini Hospital | Phase 3 |
| Unknown | Plant Versus Animal Dietary Protein and the Effect on Proteinuria NCT04058951 | Jens Rikardt Andersen | N/A |
| Completed | Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted NCT03832114 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis NCT03126201 | Istanbul University | — |
| Completed | Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria NCT03836144 | European Georges Pompidou Hospital | — |
| Completed | Recurrent Glomerulonephritis After Renal Transplantation NCT02700516 | Istanbul University | — |
| Unknown | Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis NCT02063100 | Chinese PLA General Hospital | Phase 4 |
| Terminated | Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus NCT02523768 | Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| Completed | A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy NCT01093157 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Unknown | Calcitriol in the Treatment of Immunoglobulin A Nephropathy NCT00862693 | Peking University First Hospital | Phase 4 |
| Completed | A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy NCT00426348 | Guangdong Provincial People's Hospital | Phase 4 |
| Terminated | Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis NCT00354198 | National Taiwan University Hospital | Phase 3 |
| Completed | The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy NCT00983034 | Istanbul University | N/A |
| Completed | Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor NCT00437463 | Sanofi | Phase 3 |
| Completed | Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney NCT00106561 | Melbourne Health | Phase 2 / Phase 3 |
| Completed | Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis NCT00004990 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Cyclophosphamide and Fludarabine to Treat Lupus Nephritis NCT00001676 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 1 |
| Completed | Lamivudine for Chronic Hepatitis B NCT00001457 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic NCT00345137 | Regional Hospital Holstebro | Phase 1 |